Pfizer and BioNTech announced they would seek authorization for a third dose of their Covid-19 vaccine to boost its efficacy, as the Delta variant drove devastating outbreaks in Asia and Africa and cases rose again in Europe and the United States. Delta is the most infectious strain of the virus since the start of the global pandemic early last year.
No comments:
Post a Comment